Financial Performance - Gross contract revenue for Q3 2024 was 113.9million,ayear−over−yearincreaseof20.794.4 million in Q3 2023[148] - For the nine months ended September 30, 2024, gross contract revenue reached 313.3million,reflectingayear−over−yeargrowthof23.7253.3 million in the same period of 2023[148] - Net income for Q3 2024 was 0.8million,downfrom1.2 million in Q3 2023, while Adjusted EBITDA increased to 17.0millionfrom15.1 million[148] - Adjusted EBITDA for Q3 2024 was 16.97million,withanadjustedEBITDAmarginof16.71.9 million or 12.7% to 17.0millionforthethreemonthsendedSeptember30,2024,comparedto15.1 million for the same period in 2023[195] - Adjusted EBITDA increased by 6.7millionor18.842.5 million for the nine months ended September 30, 2024, compared to 35.8millionforthesameperiodin2023[215]RevenueComposition−Thecompanyreportedthatgrosscontractrevenuederivedfromitsworkforcewas89.023.3 million to the increase in gross contract revenue for Q3 2024[175] - Revenue from emerging markets surged by 11.7millionor280.58.3 million or 24.9% to 41.7millioninQ32024,accountingfor76.813.1 million or 28.4% to 59.2millioninQ32024comparedto46.1 million in Q3 2023[186] - Total contract costs for Q3 2024 increased by 8.6millionor18.854.3 million, representing 47.7% of total contract revenue[181] - Total contract costs increased by 26.7millionor21.5150.8 million for the nine months ended September 30, 2024, compared to 124.1millionforthesameperiodin2023[202]−Directpayrollcostsincreasedby24.2 million or 25.7% to 118.5millionfortheninemonthsendedSeptember30,2024,comparedto94.3 million for the same period in 2023[203] - Total operating expenses rose by 39.8millionor31.5166.0 million for the nine months ended September 30, 2024, compared to 126.2millionforthesameperiodin2023[207]TaxandIncome−IncometaxbenefitforQ32024was1.9 million, an increase of 1.8millionfroma0.1 million benefit in Q3 2023[191] - Income tax benefit increased by 4.6millionto6.5 million for the nine months ended September 30, 2024, compared to 1.9millionforthesameperiodin2023[211]−Lossbeforetaxincreasedby2.2 million to (1.1)millionforthethreemonthsendedSeptember30,2024,comparedto1.1 million of income for the same period in 2023[192] Financing and Capital Structure - On April 1, 2024, the company raised approximately 51.1millionfromacommonstockoffering,issuing1,502,942sharesat34.00 per share[152] - The Company entered into a new 100millionrevolvingcreditfacility,replacingtheprevious70 million facility, with an outstanding balance of 32.3millionasofSeptember30,2024[228]−Interestratesonthenewrevolvingcreditfacilityrangefrom7.2228.6 million as of September 30, 2024, with fixed interest rates, indicating no exposure to market risk related to these obligations[240] - The New Credit Agreement requires compliance with certain financial covenants, including a fixed charge coverage ratio and leverage ratio of debt to EBITDA[228] - The Company is in compliance with all covenants under the New Credit Agreement as of September 30, 2024[228] Growth and Backlog - Backlog increased by 74.1millionor24.2379.8 million during the nine months ended September 30, 2024, compared to $305.7 million at December 31, 2023[217] - The Company evaluates options for capital and operational growth, considering structured debt and equity as potential sources of additional capital[229]